4.4 Article

Know your enemy - transcriptome of myxozoan Tetracapsuloides bryosalmonae reveals potential drug targets against proliferative kidney disease in salmonids

Journal

PARASITOLOGY
Volume 148, Issue 6, Pages 726-739

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S003118202100010X

Keywords

Aquatic pathogens; climate change; dual RNA-seq; minicollagen; Myxozoa; next-generation sequencing; salmonid fish

Categories

Funding

  1. University of Turku Foundation
  2. Ella and Georg Ehrnrooth Foundation
  3. Estonian Ministry of Education and Research [IUT8-2]
  4. Estonian Research Council [PRG852]
  5. German Research Foundation research fellowship [DE 2405/1-1]
  6. Swiss National Foundation [CRSII3_147649]
  7. Swiss National Science Foundation (SNF) [CRSII3_147649] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

A computational pipeline was developed to separate T. bryosalmonae transcripts and identify four protein targets for anti-parasitic drug development. Additionally, differentially expressed parasite genes in fish with varying infection levels were identified, paving the way for future genomic research and drug development.
The myxozoan Tetracapsuloides bryosalmonae is a widely spread endoparasite that causes proliferative kidney disease (PKD) in salmonid fish. We developed an in silico pipeline to separate transcripts of T. bryosalmonae from the kidney tissue of its natural vertebrate host, brown trout (Salmo trutta). After stringent filtering, we constructed a partial transcriptome assembly T. bryosalmonae, comprising 3427 transcripts. Based on homology-restricted searches of the assembled parasite transcriptome and Atlantic salmon (Salmo salar) proteome, we identified four protein targets (Endoglycoceramidase, Legumain-like protease, Carbonic anhydrase 2, Pancreatic lipase-related protein 2) for the development of anti-parasitic drugs against T. bryosalmonae. Earlier work of these proteins on parasitic protists and helminths suggests that the identified anti-parasitic drug targets represent promising chemotherapeutic candidates also against T. bryosalmonae, and strengthen the view that the known inhibitors can be effective in evolutionarily distant organisms. In addition, we identified differentially expressed T. bryosalmonae genes between moderately and severely infected fish, indicating an increased abundance of T. bryosalmonae sporogonic stages in fish with low parasite load. In conclusion, this study paves the way for future genomic research in T. bryosalmonae and represents an important step towards the development of effective drugs against PKD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available